Publicaciones en las que colabora con Carlos Manuel González (29)

2016

  1. Structural damage in rheumatoid arthritis: Comparison between tendon damage evaluated by ultrasound and radiographic damage

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1042-1046

  2. The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 609-617

  3. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?

    Rheumatology International, Vol. 36, Núm. 3, pp. 387-396

2015

  1. Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment

    Clinical Rheumatology, Vol. 34, Núm. 5, pp. 935-942

  2. Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis

    Rheumatology International, Vol. 35, Núm. 6, pp. 1021-1025

  3. Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 805-811

  4. Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 8, pp. 1408-1414

  5. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 2, pp. 141-145

2014

  1. Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?

    Rheumatology (United Kingdom), Vol. 53, Núm. 11, pp. 2088-2094

2013

  1. Anti-TNF treatments in rheumatoid arthritis: Economic impact of dosage modification

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Núm. 3, pp. 407-414

  2. Patient self-assessment and physician's assessment of rheumatoid arthritis activity: Which is more realistic in remission status? A comparison with ultrasonography

    Rheumatology (United Kingdom), Vol. 52, Núm. 12, pp. 2243-2250

  3. Ultrasound Joint Inflammation in Rheumatoid Arthritis in Clinical Remission: How Many and Which Joints Should Be Assessed?

    Arthritis Care and Research, Vol. 65, Núm. 4, pp. 512-517

2009

  1. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 61, Núm. 4, pp. 419-424

2003

  1. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage

    Lupus, Vol. 12, Núm. 11, pp. 813-819

2002

  1. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies

    Journal of Rheumatology, Vol. 29, Núm. 10, pp. 2053-2060

  2. Manifestaciones clínicas y serológicas del lupus eritematoso sistémico de inicio juvenil. Nuestra experiencia

    Acta Pediatrica Espanola, Vol. 60, Núm. 3, pp. 139-150

  3. Treatment options for juvenile-onset systemic lupus erythematosus

    Pediatric Drugs, Vol. 4, Núm. 4, pp. 241-256

1999

  1. Anticuerpos anti-U1-RNP no precipitantes en pacientes con lupus eritematoso sistemico

    Revista Espanola de Reumatologia, Vol. 26, Núm. 1, pp. 4-10

  2. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus

    Lupus, Vol. 8, Núm. 4, pp. 287-292

1998

  1. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus

    Journal of Rheumatology, Vol. 25, Núm. 9, pp. 1743-1749